You are here

Article Text

Article menu

This article has a Reply. Please see:

Download PDFPDF
Correspondence
Impact of COVID-19 pandemic on patients with SLE: results of a large multicentric survey from India
  1. Mohit Goyal1,
  2. Pravin Patil2,
  3. Himanshu Pathak3,
  4. Sham Santhanam4,
  5. Anshul Goel5,
  6. Vishnu Sharma6,
  7. Akshat Pandey7,
  8. Nikhil Gupta8,
  9. Rahul Jain9,
  10. Shashank Akerkar10,
  11. Parthajit Das11,12,
  12. Rajkiran Dudam13,
  13. Naval Mendiratta14,
  14. Bimlesh Dhar Pandey15,
  15. Mithun CB16,
  16. Bharat K Singh17,
  17. Sharath Kumar18,
  18. Nilesh Nolkha19,
  19. Shriyanka Jain20,
  20. Somya Jain21,22,
  21. Ashish Sharma15,
  22. Durga Prasanna Misra23
  1. 1 Division of Rheumatology, CARE Pain & Arthritis Centre, Udaipur, India
  2. 2 Apex Centre of Rheumatology, Pune, India
  3. 3 Department of Rheumatology, Tricolour Hospitals, Vadodara, India
  4. 4 Department of Rheumatology, Gleneagles Global Hospital, Chennai, India
  5. 5 Department of Rheumatology, Vivekanand Medical Institute, Palampur, India
  6. 6 Department of Rheumatology, Apollo Hospitals International Limited, Ahmedabad, India
  7. 7 Department of Rheumatology, Apollo Hospitals, Indore, India
  8. 8 Centre for Arthritis and Rheumatological Diseases, Delhi, India
  9. 9 Department of Rheumatology, Narayana Multispecialty Hospital, Jaipur, India
  10. 10 Mumbai Arthritis Clinic, Mumbai, India
  11. 11 Department of Rheumatology, Apollo Gleneagles Hospital, Kolkata, India
  12. 12 Department of Rheumatology, Vivekananda Institute of Medical Sciences, Kolkata, India
  13. 13 Hyderabad Rheumatology Centre, Hyderabad, India
  14. 14 Department of Rheumatology, Fortis Memorial Research Institute, Gurgaon, India
  15. 15 Division of Rheumatology, Fortis Hospital, Noida, India
  16. 16 Department of Clinical Immunology & Rheumatology, Amrita Institute of Medical Sciences, Kochi, India
  17. 17 Department of Rheumatology & Clinical Immunology, Santokba Durlabhji Memorial Hospital, Jaipur, India
  18. 18 OPTIMA Arthritis and Rheumatology Clinics, Bengaluru, India
  19. 19 Wockhardt Hospitals, Mumbai, India
  20. 20 Division of Rheumatology, Ram Krishna Care Hospital, Raipur, India
  21. 21 Department of Rheumatology, AKJ Healthcare and Diagnostics, Saharanpur, India
  22. 22 Department of Rheumatology, Max Super Speciality Hospital Dehradun, Dehradun, India
  23. 23 Department of Clinical Immunology and Rheumatology, Sanjay Gandhi Post Graduate Institute of Medical Sciences, Lucknow, India
  1. Correspondence to Dr Mohit Goyal, Rheumatology, CARE Pain & Arthritis Centre, Udaipur 313002, India; dr.mohitgoyal{at}gmail.com

http://dx.doi.org/10.1136/annrheumdis-2020-218013

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    We have read the recent report by Mathian et al with great interest where they described the clinical course of COVID-19 in 17 patients with systemic lupus erythematosus (SLE).1 The COVID-19 pandemic has caught the attention of the rheumatology fraternity due to a variety of reasons, such as the in vitro inhibition of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) by hydroxychloroquine (HCQ),2 use of tocilizumab in the treatment of cytokine storm3 and concerns regarding cardiac toxicity due to HCQ.4 Patients with SLE are routinely prescribed HCQ and other immunosuppressants. The clinical picture of COVID-19 (such as pneumonia, cardiac injury, renal injury, venous thrombosis and septic shock) in patients with SLE on long-term HCQ described by Mathian et al intrigued the global rheumatology community.1 We assessed the impact of the pandemic on Indian patients with SLE in a larger multicentric survey. We expected that differences in disease expression, ethnicity and treatment may possibly alter the impact of the pandemic in contrast to the aforementioned study. We included patients who had visited …

    View Full Text

    Footnotes

    • Twitter @drmohitgoyal, @RajkiranDudam

    • Contributors Study conception: MG and PP. Study design, data analysis and drafting the manuscript: MG, PP, HP, SS, AG and DPM. Data collection, revising the manuscript and final approval of the manuscript: all authors.

    • Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.

    • Competing interests None declared.

    • Patient and public involvement Patients and/or the public were not involved in the design, conduct, reporting or dissemination plans of this research.

    • Provenance and peer review Not commissioned; internally peer reviewed.

    Linked Articles